These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28329774)

  • 1. [Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients].
    Wawryka J; Barg E
    Pediatr Endocrinol Diabetes Metab; 2016; 22(2):60-65. PubMed ID: 28329774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed Tandem Effect of Physical Activity and Sirtuin 1 and 3 Activation in Regulating Glucose Homeostasis.
    Pacifici F; Di Cola D; Pastore D; Abete P; Guadagni F; Donadel G; Bellia A; Esposito E; Salimei C; Sinibaldi Salimei P; Ricordi C; Lauro D; Della-Morte D
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.
    Song YS; Lee SK; Jang YJ; Park HS; Kim JH; Lee YJ; Heo YS
    Diabetes Res Clin Pract; 2013 Sep; 101(3):341-8. PubMed ID: 23876548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
    Bhalla S; Gordon LI
    Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrroloquinoline quinone increases the expression and activity of Sirt1 and -3 genes in HepG2 cells.
    Zhang J; Meruvu S; Bedi YS; Chau J; Arguelles A; Rucker R; Choudhury M
    Nutr Res; 2015 Sep; 35(9):844-9. PubMed ID: 26275361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of SIRT1 in fatty liver diseases.
    Ding RB; Bao J; Deng CX
    Int J Biol Sci; 2017; 13(7):852-867. PubMed ID: 28808418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
    Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity.
    Moschen AR; Wieser V; Gerner RR; Bichler A; Enrich B; Moser P; Ebenbichler CF; Kaser S; Tilg H
    J Hepatol; 2013 Dec; 59(6):1315-22. PubMed ID: 23928404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells.
    Kozako T; Aikawa A; Shoji T; Fujimoto T; Yoshimitsu M; Shirasawa S; Tanaka H; Honda S; Shimeno H; Arima N; Soeda S
    Int J Cancer; 2012 Nov; 131(9):2044-55. PubMed ID: 22322739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells.
    Fang M; Fan Z; Tian W; Zhao Y; Li P; Xu H; Zhou B; Zhang L; Wu X; Xu Y
    Biochim Biophys Acta; 2016 Feb; 1859(2):294-305. PubMed ID: 26619800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes.
    Chang E; Kim Y
    Nutrition; 2016 Jun; 32(6):702-8. PubMed ID: 26899162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of Sirtuin 1 in Cellular Metabolism, Diabetes Mellitus, Diabetic Kidney Disease and Hypertension.
    Guclu A; Erdur FM; Turkmen K
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):131-9. PubMed ID: 26588494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of SIRT1 in ocular aging.
    Mimura T; Kaji Y; Noma H; Funatsu H; Okamoto S
    Exp Eye Res; 2013 Nov; 116():17-26. PubMed ID: 23892278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
    Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
    BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art - sirtuin 1 in kidney pathology - clinical relevance.
    Bazyluk A; Malyszko J; Hryszko T; Zbroch E
    Adv Med Sci; 2019 Sep; 64(2):356-364. PubMed ID: 31125865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1/SREBPs-mediated regulation of lipid metabolism.
    Shen S; Shen M; Kuang L; Yang K; Wu S; Liu X; Wang Y; Wang Y
    Pharmacol Res; 2024 Jan; 199():107037. PubMed ID: 38070792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microRNA-9-3p reduces lipid accumulation in HepG2 cells by targeting the expression of sirtuin type 1.
    Sun YN; Li S; Zhou YT; Liu J; Tian LB; Zhen YF; Fang H
    Mol Med Rep; 2015 Nov; 12(5):7742-8. PubMed ID: 26459099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review on SIRtuins in Diabetes.
    Aditya R; Kiran AR; Varma DS; Vemuri R; Gundamaraju R
    Curr Pharm Des; 2017; 23(16):2299-2307. PubMed ID: 28128062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.
    Pulla VK; Battu MB; Alvala M; Sriram D; Yogeeswari P
    Expert Opin Ther Targets; 2012 Aug; 16(8):819-32. PubMed ID: 22762724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic benefits from Sirt1 and Sirt1 activators.
    Chaudhary N; Pfluger PT
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):431-7. PubMed ID: 19474719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.